Mayne Pharma terminates Scheme Implementation Deed
Filed with ASX · · 2 pages · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call11 December 2025, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) (Mayne Pharma) refers to its announcement on 3 December 2025 regarding its notice of intention to terminate the scheme implementation deed dated 20 February 2025 (SID). Mayne Pharma’s 3 December 2025 notice set out details of Cosette’s material breaches of the SID. Those circumstances set out in Mayne Pharma’s notice of i
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- MYX receives purported termination notice from Cosette
- Mayne Pharma issues notice of intention to terminate the SID
- Update on FIRB condition and scheme
- Trading Halt
- Pause in Trading
Later from Mayne Pharma
- Termination of Proposed Acquisition of Mayne Pharma
- Market Update
- 2025 AGM presentation and business update
- MYX to claim against Cosette, Avista & Mr David Burgstahler
- Mayne Pharma Management Changes
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma